-
Big Data vs. Alzheimer’s
Bio-IT World | Sudeshna Das directs the data core of the Massachusetts Alzheimer’s Disease Research Center (MADRC). She recently sat down with BioTeam to discuss how MGH is collecting and working with enormous datasets to push back against Alzheimer’s.
Dec 21, 2021
-
Recursion, Roche-Genentech, Bayer Launch Multi-Million Dollar Collaborations
Bio-IT World | Last week, Recursion announced two collaborations: a new collaboration with Roche and Genentech to leverage technology-enabled drug discovery through the Recursion Operating System (OS), and an expansion of an existing Bayer collaboration focused on inferential search.
Dec 16, 2021
-
Nautilus Biotechnology Taking Protein Analysis To The Single-Molecule Level
Bio-IT World | A growing number of companies are endeavoring to replicate the success of gene sequencing juggernaut Illumina in the burgeoning field of proteomics. A top contender is Nautilus Biotechnology, which has spent the past few years drumming up excitement about the potential for comprehensively profiled proteins to make therapeutic and diagnostic development more effective and time efficient.
Dec 15, 2021
-
Seven Bridges Launches the Unified Patient Network With Genomic, EHR Data
Bio-IT World | Seven Bridges Genomics has launched a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies. The UPN will combine de-identified sequencing data and EHR content for five million patients and allow biopharma companies to license cohorts from that dataset for research. Licensing fees from biopharma will fund the network.
Dec 14, 2021
-
Why Mass Spectrometry Is Taking Over Affinity-based Approaches In Plasma Proteomics
Bio-IT World | The demand for proteomics studies has increased in recent years, with growing emphasis on datasets capturing vast amounts of proteomics data from large cohorts of patients, with thousands of proteins measured in each person. In part, this has been led by developments in computational methods, like deep learning to analyze data, as well as advancements in sample analytical methodologies.
Dec 10, 2021
-
Harvard and MIT Researchers Pursue Improved RNA and Cellular Therapies with eToehold Technology
Bio-IT World | A group of cell engineers and synthetic biologists at Harvard University and Massachusetts Institute of Technology (MIT) has developed a tech tool called “eToeholds” that could help improve the safety and efficacy of RNA and cell therapies, in addition to enabling new forms of detection.
Dec 9, 2021
-
Cupping Technique Has Standout Performance In DNA Vaccine Studies
Bio-IT World | The ultimate challenge of drug delivery—successfully getting a medicine into a cell—has several lines of pursuit when it comes to nucleic acid-based vaccines and the latest and greatest is an ancient cupping technique which, at least in rodents, is almost unfathomably good at driving immune responses. To say the Rutgers University research team was surprised by the finding would be an understatement.
Dec 8, 2021
-
Clive Brown on Field Biopsies, New Chemistry, Short Reads
Bio-IT World | At Oxford Nanopore’s virtual Community Meeting this week, CTO Clive Brown presented new chemistries, previewed the Apple iPad Pro-powered Mk1D with an integrated MinION, teased the diagnostic capacities of “outy” sequencing, unveiled a browser base caller, and more.
Dec 3, 2021
-
Follow the Money: Cloud R&D, Generative Biology, Robotics
Bio-IT World | Platforms for machine-learning generative biology and cloud R&D, drug delivery chip for therapies at the tumor site, and AI-driven drug discovery and robotics.
Dec 2, 2021
-
Cloud Hygiene and Cost Optimization at Johnson & Johnson
Bio-IT World | TRENDS FROM THE TRENCHES—Tom Messina has worked in various roles for Johnson & Johnson dating back to 1999 and is currently an IT Director in J&J’s Pharmaceutical R&D division, Janssen. BioTeam had a chance to speak with Tom recently to appreciate how J&J is leveraging cloud compute and storage resources to maximize innovation and growth while controlling costs.
Dec 1, 2021
-
Gilead Chooses AWS, Illumina, Sequoia Fund Chinese Startups, More
Bio-IT World | Illumina powers the Canadian COVID-19 Genomics Network, organ-on-a-chip explores infectious disease, and cell analysis acquisitions. Plus new products from PerkinElmer, Bio-Rad, Roswell Biotechnologies, Genialis, and more.
Nov 30, 2021


